MRP expression in non-small cell lung cancer and normal lung tissues and its prognostic significance

Chinese Journal of Lung Cancer

Volumn 8, Issue 1, 2005, Pages 32-36

  Hao, Jun ^a   Wang, Yan ^a   Li, Qingchang ^a   Wang, Enhua ^a   Qiu, Xueshan ^a   Liu, Yunpeng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Multidrug resistance associated protein; Non small cell lung cancer; Prognosis Immunohistochemistry; Western blot

Indexed keywords

BIOTIN; MULTIDRUG RESISTANCE PROTEIN; PARAFFIN; PEROXIDASE; STREPTAVIDIN;

ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; WESTERN BLOTTING;

EID: 14344258607     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Krishnamachary N, Center MS. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res, 1993, 53(16): 3658-3661.
2. Leslie EM, Ito K, Upadhyaya P, et al. Transport of the beta-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. J Biol Chem, 2001, 276(30): 27846-27854.
3. Hipfner DR, Deeley RG, Cole SP. Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta, 1999, 1461(2): 359-376.
4. Konig J, Nies AT, Cui Y, et al. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta, 1999, 1461(2): 377-394.
5. Scheffer GL, Kool M, Heijn M, et al. Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. Cancer Res, 2000, 60(18): 5269-5277.
6. Izquierdo MA, Shoemaker RH, Flens MJ, et al. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int J Cancer, 1996, 65(2): 230-237.
7. Wright SR, Boag AH, Valdimarsson G, et al. Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung. Clin Cancer Res, 1998, 4(9): 2279-2289.
8. Stein U, Lage H, Jordan A, et al. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells. Int J Cancer, 2002, 97 (6): 751-760.
9. Li XF, Kinuya S, Yokoyama K, et al. Technetium-99m-tetrofosmin would be a substrate for multidrug resistance-associated protein (MRP): comparison between a leukemia cell line with high MRP gene expression and its parental cell line. Cancer Biother Radiopharm, 2001, 16(1): 17-23.
10. Young LC, Campling BG, Cole SP, et al. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancers: correlation of protein levels with drug response and messenger RNA levels. Clin Cancer Res, 2001, 7(6): 1798-1804.
11. Oshika Y, Nakamura M, Tokunaga T, et al. Multidrug resistance-associated protein and mutant p53 protein expression in non-small cell lung cancer. Mod Pathol, 1998, 11(11): 1059-1063.
12. Young LC, Campling BG, Voskoglou-Nomikos T, et al. Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. Clin Cancer Res, 1999, 5(3): 673-680.
13. Nooter K, Bosman FT, Burger H, et al. Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Ann Oncol, 1996, 7(1): 75-81.